REGENXBIO (RGNX) R&D/CAPEX US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
R&D/CAPEX, % 618.9% 215.5% 789.1% 2 332%   8 105%  
Changes by years, y/y, % -441pp -403pp -216pp +1 543pp     +29.9%

REGENXBIO. R&D/CAPEX, %

REGENXBIO. R&D/CAPEX, changes, pp

REGENXBIO (RGNX) R&D/CAPEX US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
R&D/CAPEX, % 4 043% 4 560% 9 096% 9 455% 16 696%   8 105%
Changes by years, y/y, % +2 790pp +3 417pp +7 881pp +7 131pp +12 653pp    
Changes by quarters, q/q, % +1 719pp +517pp +4 536pp +359pp +7 241pp    

REGENXBIO. R&D/CAPEX, %

REGENXBIO. R&D/CAPEX, changes, pp

REGENXBIO. R&D/CAPEX, changes, pp